OKEP 16th September'16

Is this your test? Login to manage it. If not, you can develop a test just like it.

This is a non-interactive preview of the quiz content.

Full Name:

Territory:

Email Id:

The objective of this study was to assess the efficacy, safety, and tolerability of pantoprazole magnesium _______ once daily for _____weeks, on the relief of reflux symptoms in gastro esophageal reflux disease (GERD) patients

a. 50 mg, 8 week

b. 40 mg, 4 week

c. 30 mg, 4 week

d. 40 mg, 4 weak

In Article I, the GERD symptom intensity was made by analyzing the group of ____ patients, amongst which ___ % were females & ___% males.

a. 4343 patients, 56%, 44%

b. 4343 patients, 46%, 54%

c. 4343 patients, 54%, 46%

d. None of the above

In article I, the severity of symptoms in patients who are under study is reduced by ____% from baseline intensity, and the number of patients who experienced any adverse effect is ____%.

a. 80, 3.48

b. 30, 3.48

c. 80, 30.48

d. 90, 3.48

In article: II, the efficacy of __________ and ______ is assed in patients with functional dyspepsia.

a. Itopride, cholinesterase

b. Itopride, Dopamine

c. Itopride, Levosulpiride

d. itopride, acetyl cholinesterase effects

In article II, the study was assessed on_____ patients, ____had outcome data that could be included in analyses.

a. 554, 520

b. 554, 523

c. 550, 520

d. 551, 523

Analysis of the combined end point of pain and fullness showed that itopride yielded a _____ response than placebo.

a. 70 percent vs. 60 percent

b. 83 percent vs. 63 patient

c. 73 percent vs. 63 percent

d. None of the above

10.

Delayed gastric emptying (GE) occurs in ____% of patients with long standing type 1 or 2 diabetes, and represents a major cause of morbidity.

a. 30-54%

b. 30- 50%

c. 30%- 70%

d. None of the above

11.

Subjects received both itopride of ___ mg and placebo t.i.d. for 7 days, with a washout of 7–14 days.

a. 100 mg

b. 150 mg

c. 200 mg

d. 140 mg

12.

Eiref consists of ________ &_________

a. Pantoprazole 40 mg , Itopride SR 50 mg

b. Pantoprazole 40 mg, Itopride 150 mg

c. Pantoprazole 40 mg, Itopride SR 150 mg

d. Pantoprazole 40 mg, Itopride SR 200 mg

13.

MRP of Eiref is____/capsule.

a. 18.9/capsule

b. 17.9/capsule

c. 20/capsule

d. None of the above

Home Features Pricing FAQs Legal Sample Tests Build a Test Login/Sign Up